Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer

Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer is a phase 2, interventional study registered as NCT05228431 by Zhen-Hai Lu, with a registry enrolment figure of 121 participants, started 2022-03-02 and due to reach its primary completion in 2027-05-01. Interventions recorded: XELOX; Capecitabine monotherapy; Radiation. Conditions listed: Advanced Rectal Cancer. Primary outcome: Rate of pCR. Colorectal eligibility wording from the registry: "Pathological confirmed rectal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.